Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibroblasts | 17 | 2021 | 902 | 3.900 |
Why?
|
| Myocardium | 17 | 2021 | 1204 | 3.170 |
Why?
|
| Extracellular Matrix | 11 | 2019 | 493 | 1.540 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2021 | 126 | 1.340 |
Why?
|
| Cell Movement | 10 | 2021 | 630 | 1.190 |
Why?
|
| Heart | 8 | 2021 | 850 | 1.000 |
Why?
|
| Fibrosis | 7 | 2021 | 371 | 0.960 |
Why?
|
| Cell Proliferation | 9 | 2021 | 1174 | 0.950 |
Why?
|
| Collagen | 8 | 2021 | 636 | 0.820 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2021 | 2083 | 0.790 |
Why?
|
| Exosomes | 1 | 2021 | 44 | 0.770 |
Why?
|
| Emodin | 1 | 2021 | 21 | 0.750 |
Why?
|
| Skin, Artificial | 1 | 2019 | 4 | 0.700 |
Why?
|
| Gene Expression Regulation | 4 | 2010 | 1293 | 0.700 |
Why?
|
| Nanofibers | 1 | 2019 | 21 | 0.690 |
Why?
|
| Polyesters | 1 | 2019 | 55 | 0.680 |
Why?
|
| Isothiocyanates | 1 | 2019 | 10 | 0.660 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 111 | 0.640 |
Why?
|
| Tissue Engineering | 1 | 2019 | 212 | 0.610 |
Why?
|
| Integrins | 7 | 2019 | 115 | 0.550 |
Why?
|
| Animals | 24 | 2021 | 20881 | 0.540 |
Why?
|
| Ethanol | 2 | 2013 | 893 | 0.540 |
Why?
|
| Rats | 16 | 2013 | 5300 | 0.530 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1034 | 0.510 |
Why?
|
| Gene Expression | 2 | 2012 | 770 | 0.510 |
Why?
|
| Cells, Cultured | 10 | 2021 | 2673 | 0.490 |
Why?
|
| Cardiomyopathy, Alcoholic | 1 | 2013 | 2 | 0.440 |
Why?
|
| Organ Specificity | 1 | 2013 | 167 | 0.430 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2022 | 20 | 0.400 |
Why?
|
| Interleukins | 1 | 2012 | 79 | 0.400 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 182 | 0.390 |
Why?
|
| Mast Cells | 3 | 2012 | 113 | 0.370 |
Why?
|
| Signal Transduction | 8 | 2021 | 2689 | 0.370 |
Why?
|
| Interleukin-18 | 1 | 2010 | 16 | 0.370 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 384 | 0.360 |
Why?
|
| Actins | 2 | 2007 | 249 | 0.330 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 167 | 0.310 |
Why?
|
| Fractals | 1 | 2007 | 5 | 0.290 |
Why?
|
| Cytoskeleton | 1 | 2007 | 84 | 0.280 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 805 | 0.260 |
Why?
|
| Glucose | 1 | 2007 | 307 | 0.260 |
Why?
|
| Stress, Mechanical | 4 | 2013 | 208 | 0.260 |
Why?
|
| Angiotensin II | 1 | 2006 | 220 | 0.250 |
Why?
|
| Estradiol | 1 | 2006 | 176 | 0.250 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2019 | 144 | 0.240 |
Why?
|
| Gels | 3 | 2010 | 55 | 0.240 |
Why?
|
| Hypertension | 2 | 2010 | 1535 | 0.230 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 110 | 0.210 |
Why?
|
| Cell Communication | 2 | 2021 | 116 | 0.210 |
Why?
|
| Male | 10 | 2021 | 37321 | 0.200 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2010 | 145 | 0.200 |
Why?
|
| Cell Adhesion | 5 | 2013 | 324 | 0.200 |
Why?
|
| Matrix Metalloproteinases | 2 | 2019 | 223 | 0.190 |
Why?
|
| Smad3 Protein | 1 | 2021 | 33 | 0.190 |
Why?
|
| Smad2 Protein | 1 | 2021 | 42 | 0.190 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 186 | 0.190 |
Why?
|
| Mammary Arteries | 1 | 2021 | 18 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 110 | 0.190 |
Why?
|
| Animals, Newborn | 4 | 2007 | 396 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 134 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 150 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 147 | 0.180 |
Why?
|
| Myocardial Contraction | 2 | 2013 | 383 | 0.180 |
Why?
|
| Interleukin-6 | 2 | 2021 | 330 | 0.170 |
Why?
|
| Microscopy, Electron | 1 | 2019 | 351 | 0.170 |
Why?
|
| Blotting, Western | 4 | 2012 | 954 | 0.170 |
Why?
|
| Sulfoxides | 1 | 2019 | 16 | 0.160 |
Why?
|
| Heme Oxygenase-1 | 1 | 2019 | 40 | 0.160 |
Why?
|
| Collagen Type I | 2 | 2013 | 175 | 0.160 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2010 | 140 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 154 | 0.160 |
Why?
|
| Hydrogels | 1 | 2019 | 54 | 0.160 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 149 | 0.160 |
Why?
|
| Cattle | 1 | 2019 | 475 | 0.150 |
Why?
|
| Macrophages | 1 | 2021 | 647 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 20 | 0.150 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 247 | 0.150 |
Why?
|
| Myoblasts | 1 | 2017 | 22 | 0.150 |
Why?
|
| Models, Biological | 1 | 2021 | 981 | 0.150 |
Why?
|
| Aging | 1 | 2003 | 911 | 0.140 |
Why?
|
| Biological Assay | 2 | 2010 | 88 | 0.140 |
Why?
|
| Disease Models, Animal | 4 | 2013 | 2550 | 0.140 |
Why?
|
| Biomechanical Phenomena | 3 | 2013 | 368 | 0.140 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 181 | 0.140 |
Why?
|
| Time Factors | 3 | 2012 | 4655 | 0.140 |
Why?
|
| Enzyme Activation | 2 | 2010 | 791 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 507 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2006 | 250 | 0.120 |
Why?
|
| Dioxoles | 1 | 2013 | 8 | 0.110 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2013 | 27 | 0.110 |
Why?
|
| Cell Transdifferentiation | 1 | 2013 | 12 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2013 | 31 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 710 | 0.110 |
Why?
|
| Autocrine Communication | 1 | 2013 | 37 | 0.110 |
Why?
|
| Cell Degranulation | 1 | 2012 | 24 | 0.110 |
Why?
|
| Interleukin-33 | 1 | 2012 | 8 | 0.100 |
Why?
|
| Cell Separation | 2 | 2010 | 132 | 0.100 |
Why?
|
| Myofibroblasts | 1 | 2013 | 60 | 0.100 |
Why?
|
| Receptors, Interleukin | 1 | 2012 | 22 | 0.100 |
Why?
|
| Histocytochemistry | 1 | 2012 | 149 | 0.100 |
Why?
|
| Microscopy | 1 | 2012 | 64 | 0.100 |
Why?
|
| Benzamides | 1 | 2013 | 156 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 302 | 0.100 |
Why?
|
| Mice | 5 | 2021 | 8474 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2010 | 7 | 0.090 |
Why?
|
| Humans | 7 | 2022 | 68618 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 140 | 0.090 |
Why?
|
| Base Sequence | 1 | 2012 | 1015 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 249 | 0.090 |
Why?
|
| Nedocromil | 1 | 2009 | 7 | 0.080 |
Why?
|
| Aorta, Abdominal | 1 | 2010 | 97 | 0.080 |
Why?
|
| Pressure | 1 | 2010 | 252 | 0.080 |
Why?
|
| Echocardiography | 1 | 2012 | 515 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 337 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 331 | 0.080 |
Why?
|
| Cell Aggregation | 1 | 2007 | 28 | 0.080 |
Why?
|
| Vinculin | 1 | 2007 | 15 | 0.080 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 37 | 0.080 |
Why?
|
| Stroke Volume | 1 | 2010 | 586 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 498 | 0.070 |
Why?
|
| Ventricular Remodeling | 1 | 2010 | 318 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2006 | 19 | 0.070 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2006 | 31 | 0.070 |
Why?
|
| Disease Progression | 1 | 2010 | 1038 | 0.070 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2006 | 80 | 0.070 |
Why?
|
| Apoptosis | 1 | 2013 | 1641 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 689 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 765 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 694 | 0.070 |
Why?
|
| Estrogen Receptor alpha | 1 | 2006 | 65 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 756 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 561 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2004 | 234 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1085 | 0.060 |
Why?
|
| Cell Line | 2 | 2021 | 1752 | 0.060 |
Why?
|
| Cell Size | 1 | 2003 | 76 | 0.060 |
Why?
|
| Integrin beta Chains | 1 | 2003 | 7 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 541 | 0.060 |
Why?
|
| Integrin beta1 | 1 | 2003 | 48 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 1047 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 442 | 0.050 |
Why?
|
| Cell Extracts | 1 | 2002 | 21 | 0.050 |
Why?
|
| Palmitic Acid | 1 | 2022 | 51 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 78 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2002 | 147 | 0.050 |
Why?
|
| B7-1 Antigen | 1 | 2021 | 20 | 0.050 |
Why?
|
| Lentivirus | 1 | 2021 | 35 | 0.050 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 42 | 0.050 |
Why?
|
| Necrosis | 1 | 2022 | 239 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 2021 | 43 | 0.050 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2021 | 28 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2022 | 326 | 0.050 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2021 | 12 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2021 | 95 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2021 | 144 | 0.050 |
Why?
|
| Oligopeptides | 2 | 2012 | 152 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 244 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 658 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2021 | 218 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1745 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 370 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2017 | 3 | 0.040 |
Why?
|
| Lung | 1 | 2021 | 849 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 2791 | 0.030 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2012 | 10 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 866 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2012 | 90 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 146 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 492 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 901 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 947 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 455 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 2009 | 48 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2009 | 95 | 0.020 |
Why?
|
| Fibronectins | 1 | 2009 | 130 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 274 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 245 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2009 | 258 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 579 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 442 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1040 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1174 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2006 | 160 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2006 | 119 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1753 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 1851 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 2003 | 37 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 76 | 0.010 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2003 | 59 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 189 | 0.010 |
Why?
|